Congenital adrenal hyperplasia due to 21-hydroxylase deficiency

1. REDIRECT

Congenital adrenal hyperplasia main page
21-hydroxylase deficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 21-Hydroxylase Deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Congenital adrenal hyperplasia due to 21-hydroxylase deficiency All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
CDC on Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency in the news
Blogs on Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Directions to Hospitals Treating 21-Hydroxylase Deficiency
Risk calculators and risk factors for Congenital adrenal hyperplasia due to 21-hydroxylase deficiency